Management and Medical Therapy of Mild Hypercortisolism
Mild hypercortisolism (mHC) is defined as an excessive cortisol secretion, without the classical manifestations of clinically overt Cushing’s syndrome. This condition increases the risk of bone fragility, neuropsychological alterations, hypertension, diabetes, cardiovascular events and mortality. At...
Guardado en:
Autores principales: | Vittoria Favero, Arianna Cremaschi, Alberto Falchetti, Agostino Gaudio, Luigi Gennari, Alfredo Scillitani, Fabio Vescini, Valentina Morelli, Carmen Aresta, Iacopo Chiodini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f066ee1f63764208949ae38c0e3798e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Para entender la acción de cortisol en inflamación aguda: una mirada desde la glándula suprarrenal hasta la célula blanco
por: Guerrero,Julia
Publicado: (2017) -
Adrenal Artery Ablation for the Treatment of Hypercortisolism Based on Adrenal Venous Sampling: A Potential Therapeutic Strategy
por: Zhou Q, et al.
Publicado: (2020) -
Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs
por: Henriett Butz, et al.
Publicado: (2021) -
A Single Episode of Hypoglycemia as a Possible Early Warning Sign of Adrenal Insufficiency
por: Tanaka S, et al.
Publicado: (2020) -
The place of medical treatment of acromegaly in Serbia: Current status
por: Doknić Mirjana, et al.
Publicado: (2021)